Related Experiment Video
Updated: Jan 29, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Role of endothelial progenitor cells in diabetes mellitus
Angelo Avogaro1, Gian Paolo Fadini2
1a Dipartimento di Medicina Clinica e Sperimentale, Cattedra di Malattie del Metabolismo, Università di Padova, Via Giustiniani 2, 35128 Padova, Italy. angelo.avogaro@unipd.it.
Insights
Endothelial progenitor cells (EPCs) play a crucial role in vascular health. In diabetes, EPC dysfunction contributes to cardiovascular complications, highlighting their potential as disease biomarkers.
Area of Science:
- Cardiovascular Biology
- Endothelial Cell Biology
- Diabetes Pathophysiology
Background:
- Endothelial progenitor cells (EPCs) are vital for vascular repair and angiogenesis.
- EPCs are integral to maintaining cardiovascular health.
- Dysfunctional EPC biology is increasingly recognized in diabetes pathogenesis.
Purpose of the Study:
- To explore the role of EPCs in the development of diabetic vascular complications.
- To investigate EPCs as potential biomarkers for cardiovascular risk in diabetes.
Main Methods:
- Review of current literature on EPC biology in diabetes.
- Analysis of mechanisms underlying EPC dysfunction in diabetic patients.
Main Results:
- Derangement of EPC biology is linked to micro- and macro-vascular complications in diabetes.
- Defective EPC mobilization and reduced half-life are potential mechanisms of dysfunction.
- EPCs serve as indicators of cardiovascular risk.
Conclusions:
- EPC dysfunction is a significant factor in the pathogenesis of diabetic vascular complications.
- EPCs offer a novel pathophysiological link to understand and potentially manage diabetic complications.
Abstract:
Endothelial progenitor cells (EPCs) are bone marrow-derived cells involved in endothelial healing and angiogenesis. EPCs are considered an integrated component of the cardiovascular system, which promotes vascular health. Derangement of EPC biology in diabetes has been hailed as a novel concept in the pathogenesis of micro- and macro-vascular complications. Additionally, EPCs are considered to be disease biomarkers, as they provide an index of cardiovascular risk. The mechanisms leading to EPC dysfunction in diabetes may include defective mobilization from bone marrow to peripheral blood and reduced half-life. Hyperglycemia is considered the major determinant of microvascular complications, while other mechanisms concur to increase the risk of cardiovascular disease in diabetic patients. EPCs may represent a novel pathophysiological connection to understand development and progression of diabetic complications.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
Differentiation of Common Myeloid Progenitor Cells
Role of Microtubules in Cell Wall Deposition

